Gainers
- NexImmune (NASDAQ:NEXI) stock moved upwards by 8.3% to $3.51 during Monday's after-market session. This security traded at a volume of 109.1K shares come close, making up 76.6% of its average volume over the last 100 days. The company's market cap stands at $80.1 million.
- Avalon Globocare (NASDAQ:AVCO) stock increased by 6.29% to $0.76. The market value of their outstanding shares is at $67.1 million.
- Durect (NASDAQ:DRRX) stock increased by 4.09% to $0.6. The market value of their outstanding shares is at $136.1 million.
- BioNTech (NASDAQ:BNTX) stock moved upwards by 3.25% to $166.35. The company's market cap stands at $40.3 billion.
- Zosano Pharma (NASDAQ:ZSAN) shares increased by 3.16% to $0.22. Trading volume for this security closed at 902.5K, accounting for 7.3% of its average full-day volume over the last 100 days. The company's market cap stands at $37.4 million.
- Graybug Vision (NASDAQ:GRAY) stock rose 3.1% to $1.33. The market value of their outstanding shares is at $28.4 million.
Losers
- NeoGenomics (NASDAQ:NEO) shares fell 21.9% to $13.9 during Monday's after-market session. At the close, NeoGenomics's trading volume reached 74.1K shares. This is 7.0% of its average volume over the last 100 days. The company's market cap stands at $1.7 billion.
- Progenity (NASDAQ:PROG) shares decreased by 20.5% to $1.28. Today's trading volume for this security ended up closing at 3.1 million shares, which is 30.5 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $209.5 million. As per the news, the Q4 earnings report came out today.
- Mereo BioPharma Group (NASDAQ:MREO) shares declined by 9.16% to $1.29. The market value of their outstanding shares is at $150.9 million.
- Cormedix (NASDAQ:CRMD) shares fell 6.61% to $5.66. The market value of their outstanding shares is at $215.5 million.
- Baudax Bio (NASDAQ:BXRX) stock decreased by 6.53% to $1.72. The company's market cap stands at $11.0 million.
- Aditxt (NASDAQ:ADTX) shares declined by 6.52% to $0.43. The company's market cap stands at $18.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
